Blood Cancer

Inhibitors and targeted therapies have changed the landscape of CLL treatment, so what can patients expect from modern medicine? Dr. Jeff Sharman... Learn More

For some chronic lymphocytic leukemia (CLL) patients, the watch-and-wait period can be unsettling, leaving them wondering why a life-threatening condition hasn’t received... Learn More

CLL is different for every patient, so how do doctors tell which CLL treatment is right? Dr. Kathryn Kolibaba and Dr. Stephen... Learn More

While some chronic lymphocytic leukemia (CLL) patients are asymptomatic, the disease can cause a wide range of symptoms—and indicate disease progression. Dr.... Learn More

What is exactly going on in the body of a person with chronic lymphocytic leukemia (CLL)? Watch this video to increase your... Learn More

With genomic insights and the ability to unlock the power of DNA for treatment, is there still a place for chemotherapy? Find... Learn More

What exactly are monoclonal antibodies targeting? Dr. Stephen Spurgeon and Dr. Jeff Sharman, leading experts, dissect the scientific terminology that describes the... Learn More

Steroids can be used as a part of a CLL patient’s treatment regimen, but how do they influence the body’s ability to... Learn More

Is it safe to use supplements like herbs, vitamins and probiotics during CLL treatment? What effect could they have on your body?... Learn More

What additional CLL treatment options are available for patients who develop resistance to ibrutinib (Imbruvica)? Dr. Michael Keating, a leading CLL expert... Learn More

Is it safe for CLL patients to take blood thinners? During this “Ask the Expert” session, CLL specialist, Dr. Michael Keating, weighs... Learn More

View the replay of session one of our “Expanding Treatment Options for CLL” town meeting, as experts, Dr. Michael Keating, Dr. Jeff... Learn More

How can patients make the best treatment decisions when facing a cancer diagnosis? Join Tammy as she shares how trusting her doctor... Learn More

How often should CLL testing occur, and which tests should you have? Patient Power founder and CLL patient advocate Andrew Schorr is... Learn More

A CLL patient advocate who also has multiple sclerosis (MS), Andy shares his story during Patient Power’s recent town meeting in Denver.... Learn More

Why should a CLL patient consider participating in a clinical trial? Dr. William Wierda is joined by clinical research coordinator Patty Gibson... Learn More

CLL treatments, such as BTK Inhibitors, are becoming more commonly used in patients. Many patients wonder, how do they work? Dr. John... Learn More

What is a FISH (fluorescence in situ hybridization) test? What could it mean to have the 17p or 11q gene mutation? Patient... Learn More

Patient Power Founder Andrew Schorr was treated at MD Anderson Cancer Center more than 17 years ago with FCR (fludarabine, cyclophosphamide, rituximab)... Learn More

CLL patients have frequent blood tests. So which test results should CLL patients be most concerned about? Patient Power founder Andrew Schorr... Learn More

Andrew Schorr, Patient Power Founder and frequent host, is used to interviewing patients, physicians and care partners. As Andrew prepares to begin... Learn More

What could be the benefits of exercise for CLL patients—even during treatment? Patient Power founder Andrew Schorr poses this question to an... Learn More

When it comes to treating CLL patients, is there still a standard of care? CLL experts Dr. John Burke and Dr. William... Learn More

What CLL research did experts discuss at the recent 2017 International Workshop on Chronic Lymphocytic Leukemia (iwCLL)? In attendance at the conference... Learn More

What are lymphocyte and IgG levels, and how do they impact a patient’s CLL? Andrew Schorr, Patient Power founder, hosts this discussion... Learn More

Why do you need a bone marrow biopsy performed when you’re a CLL patient. Experts Dr. John Burke and Dr. William Wierda... Learn More

What could it mean to have an 11q or 13q or 17p deletion or other chromosomal abnormality if you are a CLL... Learn More

CLL patients can experience a range of bothersome treatment side effects–from fatigue to joint pain. How can patients work with their doctor... Learn More

Leading CLL specialists recently gathered to discuss developing research at the 2017 International Workshop on Chronic Lymphocytic Leukemia meeting, also known as... Learn More

Watch the replay of the second session of our “Living Well With CLL: Treatment & Research News” town meeting to learn tools... Learn More

Why are neutrophils and platelets monitored so closely? Andrew Schorr, Patient Power founder and host, poses this question to Drs. William Wierda... Learn More

Michele Nadeem-Baker, our CLL correspondent who is participating in a clinical trial at Dana-Farber Cancer Institute is back after her BMB (bone... Learn More

What role does CAR T-cell therapy play in targeted therapy? CLL experts Dr. Nicole Lamanna of Columbia University Medical Center and Dr.... Learn More

Joining Patient Power from the Leukemia & Lymphoma Society, Dr. Gwen Nichols and Dr. Larry Saltzman discuss the mission and services of... Learn More

This interview features Patient Power host Andrew Schorr’s online meeting with Dr. Larry Saltzman, a Sacramento-based family physician living with chronic CLL... Learn More

Where do we stand with immunotherapy for CLL patients? Experts Dr. Nicole Lamanna and Dr. Michael Keating provide an update on checkpoint... Learn More

Why hasn’t venetoclax (Venclexta) been approved as a front-line therapy for CLL? CLL experts, Dr. Nicole Lamanna and Dr. Michael Keating explain... Learn More

Powerful patient advocate Brad Adams was diagnosed in 2010 and since then has completed five cycles of FCR. Patient Power founder Andrew... Learn More

Should patients consider a clinical trial? Allen Melançon, a 17p CLL survivor who was diagnosed in 2012, visits with Patient Power founder... Learn More

Why should patients participate in support groups and advocacy? Seven-year CLL survivor and active patient advocate, Jeff Folloder, explains his involvement in... Learn More

Watch the replay of session two of our “Understanding New Options for CLL” town meeting, as a panel of experts discusses strategies... Learn More

The replay of session one of the “Understanding New Options for CLL” town meeting in Houston, as leading experts, Dr. Michael Keating... Learn More

What genetic testing should CLL patients have and when? Andrew Schorr, hosts a roundtable discussion with leading CLL experts, Dr. Jeff Sharman,... Learn More

Are there CLL treatment advances are in the pipeline, and will they be available to everyone soon? A world-renowned expert from MD... Learn More

A moving patient story from Deborah Simms, who documents her treatment journey with chronic lymphocytic leukemia (CLL). After receiving her life-changing CLL... Learn More

What tools do physicians use to determine which CLL treatment is right for a patient? Andrew Schorr, Patient Power founder, hosts a... Learn More

As part of Patient Power’s “Ask the Expert” segment, a patient asks, “What is the significance of the IGHV mutation status? When... Learn More

What challenges can CLL patients face when entering the dating world? Patient advocate Carol Preston hosts this Patient Café with three single... Learn More

Could using newer treatments, like ibrutinib (Imbruvica), as a frontline treatment decrease the future efficacy of FCR if the patient becomes refractory?... Learn More

Can dating be an issue when you have CLL? Can you be holistically intimate with someone new in your life? Carol Preston,... Learn More

How does cancer impact romantic relationship? CLL patient advocate Carol Preston hosts this Patient Café, as Jennifer and Susan describe how their... Learn More

How does your CLL diagnosis impact your relationships? Patient Power host Carol Preston introduces four CLL patients in our Patient Café. Meet... Learn More

Watch patient advocate Carol Preston, on location at the 2015 American Society of Hematology (ASH) conference, discusses the new molecule, ACP-196, a... Learn More

Are there any dietary suggestions or restrictions for patients in watch and wait? Patient Power founder, Andrew Schorr, asks CLL expert, Dr.... Learn More

Why should patients join an online discussion group? Andrew Schorr, Patient Power founder and host, wraps up this Patient Café discussion with... Learn More

Do negative messages you read on the Internet affect you? Do they make you more fearful of your diagnosis? Andrew Schorr, Patient... Learn More

Where can CLL patients find information about CLL specialists and clinical trials online? At the Patient Café, Patient Power founder and CLL... Learn More

How could patients benefit from second-generation CLL inhibitors? CLL experts Dr. Nicole Lamanna and Dr. Philip Thompson explore the top three reasons... Learn More

Should you connect with other CLL patients virtually? Andrew Schorr, Patient Power founder, met with three patients and a care partner to... Learn More

In treating CLL, where does transplant fit in? CLL experts Drs. Philip Thompson and Nicole Lamanna share their opinions on this topic.... Learn More

Could venetoclax be used soon for patients with 11q deletion? Dr. Nicole Lamanna of Columbia University Medical Center, answers a viewer’s question... Learn More

Are cosmetic procedures considered safe for chronic lymphocytic leukemia (CLL) patients? CLL expert Dr. Nicole Lamanna answers this question. Dr. Lamanna stresses... Learn More

Dr. Nicole Lamanna, a CLL specialist at Columbia University Medical Center, answers a question about treatment options for CLL patients with autoimmune... Learn More

You’ve been diagnosed with cancer. What do I do now? Patient Power Host, Carol Preston, leads this positive discussion on advice to... Learn More

How can patients best cope with emotional changes? Patient advocate Carol Preston hosts this Patient Café as Elaine, Jay, Derek and Lisa... Learn More

Will the recently approved treatment venetoclax (Venclexta) be available soon for all CLL patients? Andrew Schorr, Patient Power founder and host, asks... Learn More

Carol Preston, Patient Power Host and CLL Patient, moderates a discussion on how to be an effective member of your own cancer... Learn More

Could inhibitor treatments be used in combination with antibodies to improve complete response rates? Dr. Philip Thompson of MD Anderson Cancer Center... Learn More

What are LDH levels and what is their importance? Dr. Philip Thompson, a CLL expert from MD Anderson Cancer Center, answers a... Learn More

Why does CLL vary between patients? Andrew Schorr, Patient Power founder and host, delves into this question with two CLL specialists, Dr.... Learn More

What is the difference between being diagnosed with SLL versus CLL? Patient Power host, Andrew Schorr, asks Dr. Nicole Lamanna, a CLL... Learn More

Andrew Schorr, Patient Power founder and host, interviews three-time cancer survivor, Jennifer Abraham. Jennifer decided to view her life with cancer as... Learn More

What developing research released at ASCO this year do CLL patients need to know about? Dr. Jeff Sharman, a leading CLL expert,... Learn More

Andrew Schorr, two-time cancer survivor and Patient Power host, speaks candidly with Dr. Philip Thompson, to explore MRD (minimal residual disease) negativity... Learn More

Could body and joint aches a symptom of CLL? Dr. Philip Thompson of MD Anderson Cancer Center answers this viewer question in... Learn More

Is it possible to get the best treatment for my CLL even if I am not seeing a specialist? Andrew Schorr, who... Learn More

What are the pros and cons of continuing CLL therapies versus having a bone marrow transplant (BMT)? CLL expert Dr. Philip Thompson... Learn More

Watch the replay of the afternoon session of our “Living Well with CLL” town meeting to learn hear a panel of experts... Learn More

In the replay of the morning session of our “Living Well with CLL” town meeting, experts Dr. Nicole Lamanna and Dr. Philip... Learn More

For many, fatigue is the most common symptom of CLL. CLL expert Dr. Philip Thompson, from MD Anderson Cancer Center, answers a... Learn More

Dr. John Gribben, University of London, and Dr. Constantine Tam, Peter MacCallum Cancer Centre, join Patient Power Founder, Andrew Schorr, to discuss... Learn More

Are patients that participate in clinical trials pioneers? Andrew Schorr, Patient Power Founder, interviewed Bob Azopardi, a 16-year CLL patient who participated... Learn More

Patient Power Founder and host, Andrew Schorr interviews CLL expert Dr. Richard Furman to discuss the evolving CLL treatment landscape, including the... Learn More

Is it safe for CLL patients to get vaccinations? Are there risks involved? Andrew Schorr asks CLL expert Dr. Nicole Lamanna about... Learn More

The U.S. Food and Drug Administration (FDA) has approved a new drug Venclexta (venetoclax) for use in CLL patients with the 17p... Learn More

Dr. William Wierda, medical director of the Department of Leukemia at the University of Texas MD Anderson Cancer Center, joins Patient Power... Learn More

CLL patients have compromised immune systems, so is it safe to travel? CLL expert Dr. Michael Keating, of MD Anderson Cancer Center,... Learn More

It’s easy to focus on getting or staying physically healthy while living with CLL but what about your overall health? An expert... Learn More

For people with CLL, are supplements safe? Could they help fight CLL? In this segment, Patient Power founder Andrew Schorr poses these... Learn More

After serious adverse events were reported in patients, Gilead Sciences, Inc. has halted six clinical trials using idelalisib in combination with other... Learn More

Why are researchers and physicians so excited about combination CLL therapy? Patient Power Founder Andrew Schorr sits down with CLL experts Dr.... Learn More

Immunotherapy is personalized therapy for people with cancer–but can it outsmart CLL? Experts Drs. John Gribben, Constantine Tam,and William Wierda, along with... Learn More

What are monoclonal antibodies, and how are they used to treat CLL? From MD Anderson Cancer Center, Drs. Zeev Estrov and Michael... Learn More

Understanding all of the emerging immunotherapy options for CLL patients can be difficult. Drs. Zeev Estrov, Michael Keating, and Nicole Lamanna explore... Learn More